Cargando…

Efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations: Results from phase II and III trials

OBJECTIVES: The addition of novel β-lactamase inhibitors to carbapenems restores the activity against multidrug-resistant Gram-negative bacteria. The aim of this study was to summarize the evidence on the efficacy and safety of novel carbapenem–β-lactamase inhibitor combinations. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Wei, Shen, Ping, Luo, Qixia, Xiong, Luying, Xiao, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538188/ https://www.ncbi.nlm.nih.gov/pubmed/36211957 http://dx.doi.org/10.3389/fcimb.2022.925662

Ejemplares similares

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China
por: Yu, Wei, et al.
Publicado: (2021)

Susceptibility profile of bla (OXA-23) and metallo-β-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations
por: Sharma, Swati, et al.
Publicado: (2023)

Epidemiology and Genomic Characteristics of Bloodstream Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With Decreased Susceptibility to Aztreonam/Avibactam in China
por: Yu, Wei, et al.
Publicado: (2022)

The fecal carriage rate of extended-spectrum β-lactamase–producing or carbapenem-resistant Enterobacterales among Japanese infants in the community at the 4-month health examination in a rural city
por: Kawata, Soichiro, et al.
Publicado: (2023)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria, volume II
por: Daoud, Ziad, et al.
Publicado: (2023)

Activity fingerprinting of AMR β-lactamase towards a fast and accurate diagnosis
por: Song, Chenchen, et al.
Publicado: (2023)

Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome
por: Yu, Xiao, et al.
Publicado: (2022)

Efficacy and safety of piperacillin–tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae
por: Zhang, Wei, et al.
Publicado: (2023)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
por: Hu, Dakang, et al.
Publicado: (2022)

In vitro and in vivo Inhibitory Activity of NADPH Against the AmpC BER Class C β-Lactamase
por: Na, Jung-Hyun, et al.
Publicado: (2018)

In Vitro Activity of Auranofin in Combination With Aztreonam-Avibactam Against Metallo-β-lactamase (MBL)-Producing Enterobacterales
por: Wang, Wen, et al.
Publicado: (2021)

Occurrence of extended- spectrum β-lactamase harboring K. pneumoniae in various sources: a one health perspective
por: Yasmeen, Nafeesa, et al.
Publicado: (2023)

Safety and effectiveness of tigecycline combination therapy in renal transplant patients with infection due to carbapenem-resistant gram-negative bacteria
por: Wang, Qin, et al.
Publicado: (2023)

Predictors of Occurrence and 30-Day Mortality for Co-Infection of Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii
por: Lv, Dongmei, et al.
Publicado: (2022)

Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo
por: El Hafi, Bassam, et al.
Publicado: (2019)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
por: Peyclit, Lucie, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
por: Sophonsri, Anthony, et al.
Publicado: (2023)

Evaluation of Carbapenem Use Before and After Implementation of an Antimicrobial Stewardship-Led Carbapenem-Sparing Strategy in a Lebanese Tertiary Hospital: A Retrospective Study
por: El Masri, Mira, et al.
Publicado: (2022)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
por: Han, Xinhong, et al.
Publicado: (2021)

Emergence of Plasmids Co-Harboring Carbapenem Resistance Genes and tmexCD2-toprJ2 in Sequence Type 11 Carbapenem Resistant Klebsiella pneumoniae Strains
por: Li, Xi, et al.
Publicado: (2022)

A Sequence Type 23 Hypervirulent Klebsiella pneumoniae Strain Presenting Carbapenem Resistance by Acquiring an IncP1 bla (KPC-2) Plasmid
por: Yan, Rushuang, et al.
Publicado: (2021)

The Effect of Host Immunity on Predicting the Mortality of Carbapenem-Resistant Organism Infection
por: Lin, Qun, et al.
Publicado: (2020)

Prediction of Prognosis in Adult Patients With Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Chen, Jihui, et al.
Publicado: (2022)

Pathway Driven Target Selection in Klebsiella pneumoniae: Insights Into Carbapenem Exposure
por: Serral, Federico, et al.
Publicado: (2022)

Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene
por: Huang, Hua-Liang, et al.
Publicado: (2023)

Harmine, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium
por: Shi, Yunjia, et al.
Publicado: (2022)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant Acinetobacter baumannii in ICU Rooms
por: Zhang, Xiufeng, et al.
Publicado: (2021)

Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
por: Koskinen, Katariina, et al.
Publicado: (2021)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Corrigendum: Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene
por: Huang, Hua-Liang, et al.
Publicado: (2023)

A case report: Intermittent catheterization combined with rehabilitation in the treatment of carbapenem-resistant Klebsiella pneumoniae catheter-associated urinary tract infection
por: Shen, Lihua, et al.
Publicado: (2022)

Protective efficacy of statins in patients with Klebsiella pneumoniae bloodstream infection
por: Xu, Qian, et al.
Publicado: (2023)

Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections
por: Tenover, Fred C.
Publicado: (2021)

Carbapenemase Production and Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Western Chongqing, China
por: Huang, Wan, et al.
Publicado: (2022)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review
por: Chen, Hsin-Yu, et al.
Publicado: (2021)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_unrua23229dl7jv373pngspmpc